With advances in epidural spinal cord stimulation (eSCS) and its companion streamlined digital optimization software by StimSherpa, Dr. Zixi Zhao's project aims to obtain FDA approval of the optimization software. In the near future, the platform will be marketed and help those with spinal cord injuries by providing neuromodulation based treatments.
Jessica Froula’s project aims to explore a novel connection between the cerebellum and the thalamus. Uncovering new communication avenues by which the cerebellum engages with other brain regions may help to develop effective strategies for disease intervention via neuromodulation.
Dr. Biswaranjan Mohanty’s project aims to pioneer neuromodulation technologies to control information processing in brain circuits that can be patented, licensed, and commercialized, ultimately benefiting the state’s economy.
Ryan Webler's innovative research aims to elucidate the substrates of conscious fear appraisal which could lead to the development of more efficacious, mechanism-based anxiety, and trauma-related disorder treatments.
Haleigh Mulholland's project will provide novel insights into the circuit mechanisms underlying large-scale network formation and enhance our understanding of how systems for sensory perception emerge.
Dr. Andrew Chapp's project aims to optogenetically manipulate a specific reward pathway in the brain altered by estrogens in female mice with the goal of preventing heightened cocaine relapse behavior.
Dr. Lingling Yang's translational research project will improve our understanding of cortical network dysfunction in Parkinson’s disease (PD) and lead to more effective neuromodulation therapies for PD patients.
Michelle Thai's project aims to improve the ability of neuromodulation to treat depression, which would improve public health by promoting remission, reducing poor outcomes like suicide, and reducing the economic burden of depression.